Company profile for IN8bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

IN8bio was founded with the mission of developing next-generation cellular therapies for treating cancer. Dr. Lawrence Lamb, one the Company’s co-founders, is a leader in the field of gamma-delta T cells. During his postdoctoral fellowship in transplant medicine, he was the first to describe homeostatic reconstitution of gamma-delta T cells in patients who receive alpha-beta T cell depleted bone marrow grafts. Dr. Lamb also ...
IN8bio was founded with the mission of developing next-generation cellular therapies for treating cancer. Dr. Lawrence Lamb, one the Company’s co-founders, is a leader in the field of gamma-delta T cells. During his postdoctoral fellowship in transplant medicine, he was the first to describe homeostatic reconstitution of gamma-delta T cells in patients who receive alpha-beta T cell depleted bone marrow grafts. Dr. Lamb also identified an association between gamma-delta T cell levels and disease-free survival in allogeneic bone marrow transplantation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1500 First Avenue North Suite 103 Birmingham, AL 35203
Telephone
Telephone
+1 646.600.6GDT (6438)
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/06/3183029/0/en/IN8bio-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Business-Highlights.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/10/29/3176342/0/en/IN8bio-Expands-INB-100-Phase-1-Clinical-Trial-with-Addition-of-The-Ohio-State-University-as-New-Site.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/10/27/3174505/0/en/IN8bio-Presents-T-cell-Engager-Data-Demonstrating-Deep-B-Cell-Depletion-for-Autoimmune-Indications.html

GLOBENEWSWIRE
27 Oct 2025

https://www.globenewswire.com/news-release/2025/08/07/3129589/0/en/IN8bio-Reports-Second-Quarter-2025-Financial-Results-and-Recent-Business-Highlights.html

GLOBENEWSWIRE
07 Aug 2025

https://www.globenewswire.com/news-release/2025/06/09/3095724/0/en/IN8bio-Recognizes-Achievement-of-4-Years-in-Remission-for-Patient-Treated-with-INB-200-in-Glioblastoma-Trial.html

GLOBENEWSWIRE
09 Jun 2025

https://www.globenewswire.com/news-release/2025/06/02/3091745/0/en/IN8bio-Presents-Positive-Phase-1-Data-of-INB-200-in-Newly-Diagnosed-GBM-Demonstrating-Prolonged-Progression-Free-Survival.html

GLOBENEWSWIRE
02 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty